Bull's eye maculopathy in an HIV-positive patient receiving ritonavir

Lemuel Non; Abdallah Jeroudi; Bradley T Smith; Shadi Parsaei

doi:10.3851/IMP3007

Back

Bull's eye maculopathy in an HIV-positive patient receiving ritonavir

Journal article

Peer reviewed

Bull's eye maculopathy in an HIV-positive patient receiving ritonavir

Lemuel Non, Abdallah Jeroudi, Bradley T Smith and Shadi Parsaei

Antiviral therapy, Vol.21(4), pp.365-367

2016

DOI: 10.3851/IMP3007

PMID: 26555254

View Online

Abstract

Retinal toxicity involving the macula as a complication of the antiretroviral protease inhibitor ritonavir has been described in a few cases. We report retinal pigment epitheliopathy involving the macula with a bull's eye pattern in a 36-year-old man with well-controlled HIV receiving ritonavir with gradually progressive bilateral vision loss.

Adult

Anti-HIV Agents - administration & dosage

Anti-HIV Agents - adverse effects

Anti-HIV Agents - therapeutic use

Drug Administration Schedule

HIV Infections - drug therapy

Humans

Macular Degeneration - chemically induced

Male

Ritonavir - administration & dosage

Ritonavir - adverse effects

Ritonavir - therapeutic use

Details

Title: Subtitle: Bull's eye maculopathy in an HIV-positive patient receiving ritonavir
Creators: Lemuel Non - Washington University in St. Louis
Abdallah Jeroudi
Bradley T Smith
Shadi Parsaei
Resource Type: Journal article
Publication Details: Antiviral therapy, Vol.21(4), pp.365-367
DOI: 10.3851/IMP3007
PMID: 26555254
ISSN: 1359-6535
eISSN: 2040-2058
Language: English
Date published: 2016
Academic Unit: Infectious Diseases; Internal Medicine
Record Identifier: 9984359830102771

Metrics

23 Record Views

5 Times Cited - Web of Science

See more details